Get the Stockscreener App
10.97
5.89%
0.61
After Hours:
10.97
Neuropace Inc Stock (NPCE) Latest News
NeuroPace’s SWOT analysis: stock poised for growth amid expanding market - Investing.com
Cantor Fitzgerald Boosts Earnings Estimates for NeuroPace - MarketBeat
NeuroPACE at Leerink’s Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Cantor Fitzgerald maintains NeuroPace stock target at $20 By Investing.com - Investing.com Canada
Cantor Fitzgerald maintains NeuroPace stock target at $20 - Investing.com
NeuroPace (NASDAQ:NPCE) Announces Quarterly Earnings Results - MarketBeat
Cantor Fitzgerald Issues Positive Forecast for NeuroPace (NASDAQ:NPCE) Stock Price - MarketBeat
Cantor Fitzgerald Expects Increased Earnings for NeuroPace - Defense World
NeuroPace, Inc. (NASDAQ:NPCE) Annual Results: Here's What Analysts Are Forecasting For This Year - Simply Wall St
NeuroPace (NASDAQ:NPCE) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says - Defense World
NeuroPace Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance
NeuroPace: Strong Financial Performance and Strategic Initiatives Drive Buy Rating - TipRanks
NeuroPace, Inc. Reports Strong 2024 Growth Despite Challenges - TipRanks
Cantor raises NeuroPace stock price target to $20, maintains overweight - Investing.com India
What 4 Analyst Ratings Have To Say About NeuroPace - Benzinga
NeuroPace, Inc. (NASDAQ:NPCE) Q4 2024 Earnings Call Transcript - Insider Monkey
Cantor raises NeuroPace stock price target to $20, maintains overweight By Investing.com - Investing.com South Africa
NeuroPace Q4 2024 revenue increases 19% to USD 21.5M - Medical Buyer
NeuroPace Inc.: Q4 Earnings Snapshot - Midland Daily News
NeuroPace Inc (NPCE) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
NeuroPace Reports Strong Growth and Strategic Advancements - TipRanks
Earnings call transcript: Neuropace Q4 2024 results beat forecasts - Investing.com India
NeuroPace reports Q4 EPS (18c), consensus (22c) - TipRanks
Neuropace Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Neuropace Q4 2024 results beat forecasts By Investing.com - Investing.com UK
NeuroPace Inc SEC 10-K Report - TradingView
Neuropace earnings beat by $0.07, revenue topped estimates - Investing.com Australia
NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results -March 04, 2025 at 04:54 pm EST - Marketscreener.com
NeuroPace stock rises on Q4 earnings beat, strong 2025 outlook By Investing.com - Investing.com Australia
NeuroPace stock rises on Q4 earnings beat, strong 2025 outlook - Investing.com India
NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
NeuroPace Inc.: Q4 Earnings Snapshot -March 04, 2025 at 04:25 pm EST - Marketscreener.com
UPDATENeuroPace to Present at the Leerink Partners Global Healthcare Conference - The Manila Times
When Will NeuroPace Reveal Its Next Strategic Moves? Key Investor Conference Date Set - StockTitan
NeuroPace, Inc. to Present at Leerink Partners 2025 Global Healthcare Conference - Nasdaq
UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference - Yahoo Finance
UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference - GlobeNewswire Inc.
NeuroPace to Present at the Leerink Partners Global Healthcare Conference - The Manila Times
NeuroPace (NPCE) Projected to Post Earnings on Tuesday - Defense World
Insider Selling: NeuroPace, Inc. (NASDAQ:NPCE) Insider Sells 78,334 Shares of Stock - MarketBeat
When the Price of (NPCE) Talks, People Listen - Stock Traders Daily
NeuroPace (NPCE) to Release Quarterly Earnings on Tuesday - MarketBeat
Neuropace Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Neuropace chief medical officer Martha Morrell sells $1.07 million in stock By Investing.com - Investing.com South Africa
3.08%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):